AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Gentian Diagnostics ASA

Director's Dealing • Feb 28, 2022

3604_dirs_2022-02-28_a66e301e-3b59-4fa4-acec-b65b5efcd9bc.html

Director's Dealing

Open in Viewer

Opens in native device viewer

Mandatory notification of trade

Moss, 28 February 2022

Gentian Diagnostics ASA has today been notified that the following transaction has been completed by a primary insider in Gentian Diagnostics ASA: Tomas Kramar, board member and primary insider in Gentian Diagnostics ASA, has today bought 3,636 shares at an average price of NOK 55.94 per share. After the transaction, Tomas Kramar holds 3,636 shares in Gentian Diagnostics ASA.

Please refer to the attached notification of trading for further details.

This information is subject to the disclosure requirements in the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.

For further information, please contact: Njaal Kind, Group CFO, [email protected], +47 91 90 65 25